PfAgo-Based Zika Virus Detection.

Area of Science:

• Molecular Biology
• Virology
• Biotechnology

Background:

• Zika virus (ZIKV) poses a global health threat due to severe congenital disabilities.
• Accurate and sensitive ZIKV detection is crucial for public health.
• Existing diagnostic methods require improvement for widespread application.

Purpose of the Study:

• To develop a novel nucleic acid detection system for ZIKV.
• To evaluate the sensitivity and specificity of the new system.
• To establish a reliable diagnostic tool for ZIKV infection.

Main Methods:

• Development of a ZIKV detection system utilizing Pyrococcus furiosus Argonaute (PfAgo).
• Targeting the non-structural protein 5 (NS5) region of the ZIKV genome (ZIKV-PAND).
• Assessment of minimum detection concentration (MDC) with and without PCR amplification, compared to qRT-PCR.

Main Results:

• ZIKV-PAND achieved a minimum detection concentration (MDC) of approximately 10 nM without preamplification.
• With amplification, the MDC decreased to the attomolar (aM) level (8.3 aM), comparable to qRT-PCR (1.6 aM).
• 100% agreement was observed between ZIKV-PAND and qRT-PCR in simulated and actual ZIKV sample analyses.

Conclusions:

• The novel PfAgo-mediated ZIKV detection system (ZIKV-PAND) demonstrates high sensitivity and specificity.
• ZIKV-PAND offers a reliable alternative to qRT-PCR for ZIKV diagnosis.
• This system can facilitate molecular testing for clinical diagnosis and epidemiological surveillance of ZIKV infections.